• On 28 July 2026, Corpay announced its new Agent Card capability, which enables secure virtual card creation for AI-driven commerce workflows and extends its AI-first approach by allowing authenticated AI agents to execute controlled payments across procurement, travel, advertising, and other business processes.
• On 5 August 2026, Corpay disclosed that its Cross-Border business had earlier entered an agreement to become Ultimate Sevens’ exclusive Official FX Partner and Playmaker, supplying FX risk management tools and a single-access global payments platform to support the rugby championship’s international operations.
• We’ll now examine how Corpay’s Agent Card launch for AI-driven payments could influence the existing investment narrative around automation and growth.

Rare earth metals are an input to most high-tech devices, military and defence systems and electric vehicles. The global race is on to secure supply of these critical minerals. Beat the pack to uncover the 28 best rare earth metal stocks of the very few that mine this essential strategic resource.

Corpay Investment Narrative Recap

To own Corpay, I think you have to believe it can stay central to B2B payments as customers automate and move money across borders, even as new rails and competitors emerge. The Agent Card launch and the Ultimate Sevens FX deal both support that automation and cross border story, but do not appear to change the current near term catalyst around broader payables digitization, or the key risk that alternative payment ecosystems could gradually bypass Corpay’s platforms.

The Agent Card announcement is most closely tied to the automation catalyst, because it embeds Corpay’s virtual card controls directly into AI driven procurement, travel, and advertising workflows. If businesses continue to build AI based processes around Corpay’s infrastructure, that could reinforce its position in automated payables and help offset pressures from rising compliance costs and more crowded competition for corporate payment volumes.

Yet behind the AI and cross border momentum, investors should also be aware that growing alternative payment rails could eventually...

Corpay's narrative projects $6.6 billion revenue and $2.1 billion earnings by 2029. This requires 11.1% yearly revenue growth and a roughly $0.9 billion earnings increase from $1.2 billion today.

Uncover how Corpay's forecasts yield a $395.14 fair value, in line with its current price.

Exploring Other Perspectives

Four fair value estimates from the Simply Wall St Community range from US$350.44 to an extreme outlier above US$633,888,868,000, underlining how far apart individual views can be. Against that backdrop, Corpay’s push into AI driven payment automation invites you to weigh how much ongoing platform relevance in a changing payments infrastructure might matter for its future performance and to compare several of these alternative viewpoints.

Explore 4 other fair value estimates on Corpay - why the stock might be worth 12% less than the current price!

Decide For Yourself

Disagree with existing narratives? Extraordinary investment returns rarely come from following the herd, so go with your instincts.

• A great starting point for your Corpay research is our analysis highlighting 3 key rewards and 2 important warning signs that could impact your investment decision.
• Our free Corpay research report provides a comprehensive fundamental analysis summarized in a single visual - the Snowflake - making it easy to evaluate Corpay's overall financial health at a glance.

Looking For Alternative Opportunities?

The market won't wait. These fast-moving stocks are hot now. Grab the list before they run:

• The future of work is here. Discover the 35 top robotics and automation stocks leading the charge in AI-driven automation and industrial transformation.
• The best AI stocks today may lie beyond giants like Nvidia and Microsoft. Find the next big opportunity with these 16 smaller AI-focused companies with strong growth potential through early-stage innovation in machine learning, automation, and data intelligence that could fund your retirement.
• AI is about to change healthcare. These 41 stocks are working on everything from early diagnostics to drug discovery. The best part - they are all under $10b in market cap - there's still time to get in early.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.